Objectives
Ovarian cancer is the second most common gynecologic cancer in the United States and has the highest mortality rate of any gynecologic cancer. There is no simple and reliable way to screen for ovarian cancer, so it is especially important that health care practitioners help their patients recognize and discuss risk factors and warning signs.
ACOG is pleased to offer the free online course Prevention and Early Diagnosis of Ovarian Cancer, which summarizes the relevant literature and existing recommendations to guide clinicians in the equitable prevention, early diagnosis, and special considerations of ovarian cancer.
The learning objectives are to:
- Identify risk factors for ovarian cancer.
- Summarize key health disparities in ovarian cancer.
- Identify effective methods for risk modification and early diagnosis of ovarian cancer.
Developed through a partnership with the Centers for Disease Control and Prevention, this course is available to women's health care practitioners including obstetrician-gynecologists, nurses, nurse practitioners, physician assistants, family physicians, medical students and residents, and allied health professionals.
Credits
ACCME Accreditation
The American College of Obstetricians and Gynecologists is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA PRA Category 1 Credit(s)™
The American College of Obstetricians and Gynecologists designates this enduring material for a maximum of 7 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
College Cognate Credit(s)
The American College of Obstetricians and Gynecologists designates this enduring material for a maximum of 7 Category 1 College Cognate Credits. The College has a reciprocity agreement with the AMA that allows AMA PRA Category 1 Credits™ to be equivalent to College Cognate Credits.
American Nurses Credentialing Center's Commission on Accreditation
This nursing continuing professional development activity was approved by the Maryland Nurses Association, an accredited approver by The American Nurses Credentialing Center's Commission on Accreditation. The last date learners will be able to access this activity to receive contact hours is December 1, 2024.
Evaluation Survey
Complete the course evaluation survey. Thank you for your feedback!
Conflict of Interest Disclosure
This project was supported by the Centers for Disease Control and Prevention of the Department of Health and Human Services under cooperative agreement number 6 NU38OT000287-04-03, which was awarded to ACOG. All authors received a one-time payment from ACOG for their participation in the development of ovarian cancer educational materials.
All authors, contributors, reviewers and staff have submitted a conflict-of-interest disclosure statement, and any potential conflicts have been considered and managed in accordance with ACOG's Conflict of Interest Disclosure Policy. This policy, along with ACOG's Privacy Policy, can be found at acog.org.
RELEVANT FINACIAL RELATIONSHIPS: FACULTY/PLANNING COMMITTEE MEMBERS/REVIEWERS/STAFF
ALL RELEVANT FINACIAL RELATIONSHIPS HAVE BEEN MITIGATED
- Rebecca Brooks, MD: "Speakers Bureau: AstraZeneca; Advisory Board: Tempus and GSK/Merck"
- Leigha Senter-Jamieson, MD: "Consultant/Speaker: AstraZeneca; Advisor: GSK"
- Wenora Johnson: "Patient Advocate Advisory Member: Blue Note Therapeutics and Flatron Health; Consultant: Bristol Myers Squibb"
- Shilpa Shahani, MD: "Consultant: Kite; Speakers Bureau: Amgen"
ALL OTHER FACULTY/PLANNING COMMITTEE MEMBERS/REVIEWERS/STAFF HAVE NO RELEVANT FINANCIAL RELATIONSHIPS WITH INELIGIBLE COMPANIES.
Earn CME Credit
ACOG eModules—a practical, self-evaluation program—feature a pretest, clinically-oriented multiple-choice knowledge check questions, and a posttest with a rich discussion of the content.
Earn a maximum of 7 College Cognate credits or 7 AMA PRA Category 1 Credit(s)™.
Access Course